Glucotrack, Inc. (GCTK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 200K 400K 600K Q4 '15: 0 Q1 '16: 89.1K Q2 '16: 381.7K Q3 '16: 11.3K Q4 '16: 129.5K Q1 '17: 96.2K Q2 '17: 8.7K Q3 '17: 20.9K Q4 '17: 463.6K Q1 '18: 28.2K Q2 '18: 15.3K Q3 '18: 0 Q4 '18: 0 Q1 '19: 25.6K Q2 '19: 110.5K Q3 '19: 4.2K Q4 '19: 67.7K Q1 '20: 2.2K Q2 '20: 97 Q3 '20: 0 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19 Q3 '20

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -767K Q4 '21: -1.5M Q1 '22: -1.1M Q2 '22: -1.1M Q3 '22: -929K Q4 '22: -1.3M Q1 '23: -1.3M Q2 '23: -1.2M Q3 '23: -2.2M Q4 '23: -2.4M Q1 '24: -3M Q2 '24: -4.5M Q3 '24: -3.3M Q4 '24: -3.9M Q1 '25: -3.5M Q2 '25: -4.8M Q3 '25: -4.3M Q4 '25: -3.5M Q1 '26: -4.2M Q2 '26: -3.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -804K Q4 '21: -1.5M Q1 '22: -1.1M Q2 '22: -1.1M Q3 '22: -928K Q4 '22: -1.3M Q1 '23: -1.3M Q2 '23: -1.2M Q3 '23: -2.2M Q4 '23: -2.4M Q1 '24: -2.9M Q2 '24: -4.5M Q3 '24: -5.1M Q4 '24: -10.1M Q1 '25: -6.8M Q2 '25: -4.8M Q3 '25: -4.2M Q4 '25: -3.6M Q1 '26: -4.3M Q2 '26: -3.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -894K Q4 '21: -973K Q1 '22: -1.3M Q2 '22: -916K Q3 '22: -608K Q4 '22: -940K Q1 '23: -1.3M Q2 '23: -954K Q3 '23: -1.9M Q4 '23: -2.4M Q1 '24: -2.9M Q2 '24: -1.9M Q3 '24: -4.1M Q4 '24: -3.5M Q1 '25: -2.9M Q2 '25: -3.7M Q3 '25: -4.6M Q4 '25: -3.9M Q1 '26: -4M Q2 '26: -3.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q4 '18: -1.1M Q1 '19: -827.4K Q2 '19: -1.2M Q3 '19: -1.1M Q4 '19: -796.9K Q1 '20: -1M Q2 '20: -903K Q3 '20: -796K Q4 '20: -851K Q3 '21: -894K Q4 '21: -977K Q3 '22: -608K Q1 '24: -3M Q2 '24: -1.9M Q3 '24: -4.2M Q4 '24: -3.5M Q1 '25: -2.9M Q2 '25: -3.7M Q3 '25: -4.7M Q4 '25: -4M Q1 '19 Q4 '19 Q3 '20 Q4 '21 Q2 '24 Q1 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6B 12B 18B Q3 '18: 8.2M Q2 '19: 149.8M Q3 '19: 162M Q1 '21: 15.4B Q2 '21: 15.4M Q3 '21: 15.5M Q1 '22: 15.5M Q2 '22: 15.5M Q3 '22: 15.5M Q1 '23: 15.5M Q2 '23: 4.3M Q3 '23: 4.6M Q1 '24: 249.6K Q2 '24: 4.6K Q3 '24: 4.7K Q1 '25: 169.3K Q2 '25: 494.5K Q3 '25: 899.4K Q1 '26: 1.6M Q2 '26: 5M Q2 '19 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1500.00 3000.00 4500.00 Q4 '20: 0.24 Q1 '21: 0.24 Q2 '21: 0.22 Q3 '21: 0.20 Q4 '21: 0.32 Q1 '22: 0.25 Q2 '22: 0.24 Q3 '22: 0.23 Q4 '22: 0.29 Q1 '23: 0.28 Q2 '23: 0.62 Q3 '23: 0.19 Q4 '23: 35.26 Q1 '24: 23.61 Q2 '24: 1007.34 Q3 '24: 2099.83 Q4 '24: 3302.27 Q1 '25: 3354.14 Q2 '25: 2379.76 Q3 '25: 1292.40 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.